![](/img/cover-not-exists.png)
905 ADHERENCE WITH TELAPREVIR BID vs. q8h DOSING IN TREATMENT-NAÏVE HCV-INFECTED PATIENTS: RESULTS FROM THE PHASE III OPTIMIZE STUDY
Sievert, W., Buti, M., Agarwal, K., Horsmans, Y., Zeuzem, S., Janczewska, E., Nyberg, L., Brown, R.S., Hezode, C., Rizzetto, M., Parana, R., De Meyer, S., De Masi, R., Luo, D., Witek, J.Volume:
58
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(13)60907-1
Date:
April, 2013
File:
PDF, 57 KB
english, 2013